Connor, Clark & Lunn Investment Management (CC&L)’s Bio-Techne TECH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Buy	+6,223	New	+$336K	﹤0.01%	1424
2026 Q1	–	Sell	-89,408	Closed	-$5.26M	–	1762
2025 Q4	$5.26M	Buy	89,408 +61,643	+222%	+$3.75M	0.01%	630
2025 Q3	$1.54M	Buy	+27,765	New	+$1.49M	﹤0.01%	935
2022 Q4	–	Sell	-20,236	Closed	-$1.44M	–	1425
2022 Q3	$1.44M	Buy	20,236 +10,904	+117%	+$942K	0.01%	572
2022 Q2	$809K	Buy	+9,332	New	+$875K	﹤0.01%	668
2021 Q4	–	Sell	-15,604	Closed	-$1.89M	–	1198
2021 Q3	$1.89M	Buy	+15,604	New	+$1.9M	0.01%	532
2019 Q4	–	Sell	-4,300	Closed	-$210K	–	1088
2019 Q3	$210K	Buy	+4,300	New	+$216K	﹤0.01%	856
2014 Q2	–	Sell	-8,800	Closed	-$207K	–	629
2014 Q1	$207K	Buy	+8,800	New	+$198K	﹤0.01%	616

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TECH Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Bio-Techne (TECH) in Q2 2026: 6,223 shares worth $440K. The stake represents ﹤0.01% of the portfolio and ranks #1424 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in TECH as recently as Q4 2025.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TECH in Q1 2014 and has held it in 8 quarters since. The position peaked at $5.26M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 6,223 shares of Bio-Techne worth $440K as of Q2 2026.
Bio-Techne was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q2 2026.
Bio-Techne made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1424 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Bio-Techne in Q1 2014 and has held it in 8 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Bio-Techne position peaked at $5.26M in Q4 2025.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.